Literature DB >> 16903459

Case-control retrospective study of pulmonary tuberculosis in heroin-abusing patients in China.

Weihua Wang1, Hong Xiao, Lanying Lu.   

Abstract

The objective of this study was to observe the clinical significance of pulmonary tuberculosis in heroin abusers. A case-retrospective study was done to analyze clinical symptoms and severity based on chest X-rays, results of sputum bacterial test and effects of treatment. The clinical symptoms in patients with tuberculosis and heroin addiction were more severe than those in the nonheroin-addicted group. An examination of chest X-rays showed that tuberculosis lesions were involved in two or more lung fields in 80% of the heroin-addicted cases. In 73.3% of the cases, sputum bacterial tests were positive for tuberculosis. After anti-tuberculosis treatment, chest X-rays showed a recovery rate of 46.67%, caves became smaller by 41.7%, and the sputum negative conversion rate was 45.5%. There are significant differences compared with the control group (p < 0.05). The patients with pulmonary tuberculosis combined with heroin addiction had more severe clinical symptoms, more lesion zones found in their chest X-rays, higher sputum tuberculosis positive rates, and poorer treating effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16903459     DOI: 10.1080/02791072.2006.10399844

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  3 in total

1.  Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients.

Authors:  Elinore F McCance-Katz; David E Moody; Sudha Prathikanti; Gerald Friedland; Petrie M Rainey
Journal:  Drug Alcohol Depend       Date:  2011-05-19       Impact factor: 4.492

Review 2.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

3.  Risk for latent and active tuberculosis in Germany.

Authors:  Christian Herzmann; Giovanni Sotgiu; Oswald Bellinger; Roland Diel; Silke Gerdes; Udo Goetsch; Helga Heykes-Uden; Tom Schaberg; Christoph Lange
Journal:  Infection       Date:  2016-11-19       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.